Biocardia Stock Price Prediction

BCDA Stock  USD 2.28  0.09  3.80%   
At this time, the RSI of Biocardia's share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Biocardia, making its price go up or down.

Oversold Vs Overbought

45

 
Oversold
 
Overbought
The successful prediction of Biocardia's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Biocardia, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Biocardia's stock price prediction:
EPS Estimate Current Year
(3.52)
EPS Estimate Next Year
(1.22)
Wall Street Target Price
25
Quarterly Revenue Growth
(0.93)
Using Biocardia hype-based prediction, you can estimate the value of Biocardia from the perspective of Biocardia response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biocardia to buy its stock at a price that has no basis in reality. In that case, they are not buying Biocardia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Biocardia after-hype prediction price

    
  USD 2.36  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Biocardia Basic Forecasting Models to cross-verify your projections.
For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.132.6414.80
Details
Naive
Forecast
LowNextHigh
0.052.3014.45
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.3-0.3-0.3
Details

Biocardia After-Hype Price Prediction Density Analysis

As far as predicting the price of Biocardia at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biocardia or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biocardia, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Biocardia Estimiated After-Hype Price Volatility

In the context of predicting Biocardia's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biocardia's historical news coverage. Biocardia's after-hype downside and upside margins for the prediction period are 0.12 and 14.52, respectively. We have considered Biocardia's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.28
2.36
After-hype Price
14.52
Upside
Biocardia is extremely dangerous at this time. Analysis and calculation of next after-hype price of Biocardia is based on 3 months time horizon.

Biocardia Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Biocardia is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biocardia backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biocardia, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.61 
12.16
  0.08 
  0.09 
9 Events / Month
13 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.28
2.36
3.51 
9,354  
Notes

Biocardia Hype Timeline

Biocardia is currently traded for 2.28. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.09. Biocardia is forecasted to increase in value after the next headline, with the price projected to jump to 2.36 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.51%, whereas the daily expected return is currently at 0.61%. The volatility of related hype on Biocardia is about 8251.43%, with the expected price after the next announcement by competition of 2.37. Biocardia currently holds 1.31 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days.
Check out Biocardia Basic Forecasting Models to cross-verify your projections.
For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.

Biocardia Related Hype Analysis

Having access to credible news sources related to Biocardia's direct competition is more important than ever and may enhance your ability to predict Biocardia's future price movements. Getting to know how Biocardia's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biocardia may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AVTEAerovate Therapeutics(0.02)3 per month 2.13  0.13  5.58 (3.86) 19.11 
ADAGAdagene 0.02 5 per month 0.00 (0.05) 8.13 (9.52) 37.93 
ACRVAcrivon Therapeutics, Common 0.1 6 per month 0.00 (0.11) 7.66 (7.65) 22.84 
RZLTRezolute(0.28)7 per month 3.08  0.03  6.81 (5.54) 30.01 
ANTXAN2 Therapeutics 0.01 9 per month 1.86  0.08  3.73 (3.42) 28.03 
ZIVOZivo Bioscience 0.04 4 per month 0.00 (0.17) 5.31 (6.67) 36.36 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
ERASErasca Inc 0.03 7 per month 3.66 (0.01) 7.34 (5.38) 17.38 
FBRXForte Biosciences 3.09 5 per month 3.41  0.11  6.65 (6.33) 126.20 
AMTIApplied Molecular Transport(0.02)1 per month 5.70  0.01  11.11 (10.34) 36.60 
ABVCABVC Biopharma(0.03)2 per month 0.00 (0.08) 7.25 (9.09) 35.84 
INDPIndaptus Therapeutics 0.03 10 per month 0.00 (0.08) 12.60 (9.40) 49.41 
KTTAPasithea Therapeutics Corp(0.15)5 per month 0.00 (0.04) 8.27 (11.00) 68.44 
BTTXBetter Therapeutics(0.33)62 per month 0.00 (0.14) 12.64 (9.62) 36.53 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.04) 8.61 (11.48) 76.00 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.42  0.02  6.27 (5.79) 20.98 
NGENFNervGen Pharma Corp 0.00 0 per month 4.56 (0.02) 6.79 (6.09) 33.14 
PTIXProtagenic Therapeutics 0.06 4 per month 7.00  0.03  18.33 (12.07) 47.50 
MIROMiromatrix Medical(0.06)2 per month 5.26  0.05  11.73 (8.87) 38.49 

Biocardia Additional Predictive Modules

Most predictive techniques to examine Biocardia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocardia using various technical indicators. When you analyze Biocardia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biocardia Predictive Indicators

The successful prediction of Biocardia stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biocardia, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biocardia based on analysis of Biocardia hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biocardia's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biocardia's related companies.
 2023 2024 (projected)
Dividend Yield0.30.27
Price To Sales Ratio29.4828.01

Story Coverage note for Biocardia

The number of cover stories for Biocardia depends on current market conditions and Biocardia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biocardia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biocardia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Biocardia Short Properties

Biocardia's future price predictability will typically decrease when Biocardia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biocardia often depends not only on the future outlook of the potential Biocardia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biocardia's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.4 M
Cash And Short Term Investments1.1 M

Complementary Tools for Biocardia Stock analysis

When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios